Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by staolinon Nov 16, 2010 4:07pm

825 Views

Post# 17714670

RE: RE: RE: RE: ouch what the F just happened?

Ask yourself why someone would drop 80k shares at market price, bringing the share price down from 6.75 to 5.75, when they could have sold those 80k shares at 6.50+ all day.
They caused a panic selloff of 350k shares in the last 20 mins, caused the market price to drop from 6.75 to close at 4.5. A handful of shares went for 4.35.
Thanks. I was looking thinking over 6.5 was too risky for my sensitive gambling self. Then an angel magically drops the sp 2$ to 4.5.
Many thanks. Still a gamble, just one I'm a little more comfortable with.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row